Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: the COVID-HEART study

niversity of Leeds0 个研究点目标入组 386 人开始时间: 2020年8月4日最近更新: 2024年9月9日

适应症

试验速览

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34112195/ (added 14/06/2021) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36705028/ (added 30/01/2023) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/39207330/ (added 02/09/2024)

•1. Aged = 18 years
•2. Diagnosed with SARS-CoV-2 infection with a raised cardiac biomarker (Troponin)

•1. Unable/unwilling to consent
•2. Significant renal impairment (eGFR<30ml/min/m²)
•3. Female participants who are pregnant, lactating or planning pregnancy during the course of the study
•4. Contraindications to MRI (pacemaker, intra-orbital debris, intra-orbital debris, intra-auricular implants, intracranial clips, severe claustrophobia
•5. Known hypersensitivity to gadolinium-based contrast agents

发起方

niversity of Leeds